Sympatholytic

WikiDoc Resources for Sympatholytic
Articles
Most recent articles on Sympatholytic Most cited articles on Sympatholytic Review articles on Sympatholytic Articles on Sympatholytic in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Sympatholytic Images of Sympatholytic Photos of Sympatholytic Podcasts & MP3s on Sympatholytic Videos on Sympatholytic
Evidence Based Medicine
Cochrane Collaboration on Sympatholytic Bandolier on Sympatholytic TRIP on Sympatholytic
Clinical Trials
Ongoing Trials on Sympatholytic at Clinical Trials.gov Trial results on Sympatholytic Clinical Trials on Sympatholytic at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Sympatholytic NICE Guidance on Sympatholytic NHS PRODIGY Guidance FDA on Sympatholytic CDC on Sympatholytic
Books
Books on Sympatholytic
News
Sympatholytic in the news Be alerted to news on Sympatholytic News trends on Sympatholytic
Commentary
Blogs on Sympatholytic
Definitions
Definitions of Sympatholytic
Patient Resources / Community
Patient resources on Sympatholytic Discussion groups on Sympatholytic Patient Handouts on Sympatholytic Directions to Hospitals Treating Sympatholytic Risk calculators and risk factors for Sympatholytic
Healthcare Provider Resources
Symptoms of Sympatholytic Causes & Risk Factors for Sympatholytic Diagnostic studies for Sympatholytic Treatment of Sympatholytic
Continuing Medical Education (CME)
CME Programs on Sympatholytic
International
Sympatholytic en Espanol Sympatholytic en Francais
Business
Sympatholytic in the Marketplace Patents on Sympatholytic
Experimental / Informatics
List of terms related to Sympatholytic

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

A sympatholytic is a medication which inhibits the functioning of the sympathetic nervous system (SNS). They are used as antihypertensives.

They mainly comprise antiadrenergic agents, but also anticholinergics in the case of the nicotinic antagonist, since nicotinic receptors relay the signals of the SNS across the ganglia.

Antiadrenergic

Antiadrenergic agents inhibit the signals of adrenaline and noradrenaline. They are mainly adrenergic antagonists, inhibiting adrenergic receptors, but there are exceptions: clonidine is an adrenergic agonist on the α2 receptor, since this receptor is located presynaptically to inhibit further release of adrenaline and noradrenaline.

Other ways of inhibiting adrenergic signaling is by catecholamine synthesis blocking, e.g. by methyltyrosine. Reserpine works by inhibiting transport into synaptic vesicles of noradrenaline by inhibiting the VMAT transporter.

In hypotension

Many antiadrenergic agents used as antihypertensives include:

• centrally acting:
  • Clonidine (α2 agonist)
  • Guanfacine (α2 agonist)
  • Methyldopa (α2 agonist)
  • Moxonidine (imidazoline receptor agonist)
  • Rescinnamine (ACE inhibitor)
  • Reserpine (VMAT inhibitor)
  • Rilmenidine (imidazoline receptor agonist)
• ganglion-blocking
  • Mecamylamine (α3β4 nicotinic receptor inhibitor)
  • Trimethaphan (ganglion type receptor inhibitor)
• peripherally acting
  • Prazosin (α1 antagonist)
  • Guanethidine (Magnesium-ATPase inhibitor)
  • Indoramin (α1 antagonist)
  • Doxazosin (alpha blocker)

External links

• Sympatholytics at the US National Library of Medicine Medical Subject Headings (MeSH)
• Template:Dorlands